Celltrion Stock

Celltrion FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Celltrion (068270.KS) as of Aug 15, 2026 is 134.46 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 34.24 % — a change of 292.65% (higher).

FCF Conversion

134.46 %

YoY

292.65%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Celltrion is 2026 134.46 % . FCF Conversion Rate (FCF/EBITDA) of Celltrion was 2025 34.24 % . It decreases by 292.65% higher compared to the previous year.
Access this data via the Eulerpool API

Celltrion Stock analysis

What does Celltrion do? Celltrion Inc is a South Korean company that was founded in 2002 and specializes in the development and manufacturing of biopharmaceutical products. The company is headquartered in Incheon, South Korea and employs over 2,000 people worldwide. Celltrion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Celltrion stock

FCF Conversion Rate (FCF/EBITDA) of Celltrion is 134.46 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Celltrion changed from 34.24 % to 134.46 %, representing a 292.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Celltrion since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Celltrion with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Celltrion

All Key Metrics — Celltrion